US Genomics, catapulted to industry attention with Craig Venter’s endorsement and its buzzed-about video of unspooling single molecules of DNA, has embarked on raising a fourth round of private equity investment, hoping to secure enough money to last the company three years, according to CEO Eugene Chan.
“We want to raise enough money to take us to profitability and a public offering before three years are up, maybe as early as 18 months,” he says.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
